Abequolixron

RGX-104

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abequolixron, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Abequolixron (RGX-104) and Durvalumab in Lung Cancer [Phase 1]